World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
49
Citations
10336
World Ranking
3993
National Ranking
207

Claude Houdayer publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where Claude Houdayer sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 148 publications — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

Claude Houdayer D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where Claude Houdayer sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 49 D-Index — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Overview

Claude Houdayer is affiliated with the Centre Hospitalier Universitaire de Rouen in France. Their research activity spans several intersecting areas of biochemistry, genetics, molecular biology, and medicine, with a focus on oncology, pathology, and forensic medicine.

The scientist's work centers on key topics including:

  • BRCA gene mutations in cancer
  • Genetic factors in colorectal cancer
  • Cancer-related molecular pathways
  • Genomic variations and chromosomal abnormalities
  • Genomics and rare diseases
  • RNA modifications and cancer
  • Ocular oncology and treatments

Claude Houdayer has contributed to a variety of recent publications that reflect these interests. Notable papers include:

  • "A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression," 2021, published in Nature Communications
  • "Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome," 2022, JNCI Journal of the National Cancer Institute
  • "Assessment of Multiplex Digital Droplet RT-PCR as a Diagnostic Tool for SARS-CoV-2 Detection in Nasopharyngeal Swabs and Saliva Samples," 2020, Clinical Chemistry
  • "MYT1L-associated neurodevelopmental disorder: description of 40 new cases and literature review of clinical and molecular aspects," 2021, Human Genetics
  • "Skipping Nonsense to Maintain Function: The Paradigm of BRCA2 Exon 12," 2020, Cancer Research

The scientist frequently collaborates with several researchers, including:

  • Dominique Stoppa-Lyonnet
  • Lisa Golmard
  • Sandrine M. Caputo
  • Thierry Frébourg
  • Stéphanie Baert-Desurmont

Claude Houdayer's research is often published in venues that focus on cancer biology and genetics. The most frequent publication outlets include:

  • Cancers
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Research
  • Familial Cancer
  • Nature Communications

Their scholarly output brings together an interdisciplinary approach, combining molecular biology and genetics to advance understanding in cancer research and related medical fields. This profile reflects an extensive body of work contributing to ongoing developments in genetic determinants of cancer and molecular diagnostics.

Best Publications

  • Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes.

    Shinji Kondo;Brian C. Schutte;Rebecca J. Richardson;Bryan C. Bjork

  • Ploidy and Large-Scale Genomic Instability Consistently Identify Basal-like Breast Carcinomas with BRCA1/2 Inactivation

    Tatiana Popova;Elodie Manié;Guillaume Rieunier;Virginie Caux-Moncoutier

  • Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

    Timothy R. Rebbeck;Nandita Mitra;Fei Wan;Olga M. Sinilnikova

  • A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population

    Antonis C. Antoniou;Xianshu Wang;Zachary S. Fredericksen;Lesley McGuffog

  • Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies.

    Diane E Rushlow;Berber M Mol;Jennifer Y Kennett;Stephanie Yee;Stephanie Yee

  • Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

    Antonis C. Antoniou;Antonis C. Antoniou;Amanda B. Spurdle;Amanda B. Spurdle;Olga M. Sinilnikova;Olga M. Sinilnikova;Sue Healey;Sue Healey

  • Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

    Fergus J. Couch;Xianshu Wang;Lesley McGuffog;Andrew Lee

  • Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families

    Xin Yang;Goska Leslie;Alicja Doroszuk;Sandra Schneider

  • Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants.

    Claude Houdayer;Virginie Caux-Moncoutier;Sophie Krieger;Michel Barrois

  • Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes

    Thierry Frebourg;Svetlana Bajalica Lagercrantz;Carla Oliveira;Rita Magenheim

  • Evaluation of in silico splice tools for decision‐making in molecular diagnosis

    Claude Houdayer;Catherine Dehainault;Christophe Mattler;Dorothée Michaux

  • Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSF.

    C. Houdayer;M. Gauthier-Villars;A. Laugé;S. Pagès-Berhouet

  • Mutation of SFTPC in infantile pulmonary alveolar proteinosis with or without fibrosing lung disease

    Mohammed Tredano;Matthias Griese;Frank Brasch;Silja Schumacher

  • Contiguous gene deletion within chromosome arm 10q is associated with juvenile polyposis of infancy, reflecting cooperation between the BMPR1A and PTEN tumor-suppressor genes.

    Capucine Delnatte;Damien Sanlaville;Jean François Mougenot;Joris Robert Vermeesch

  • Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes.

    Véronique Gelsi-Boyer;Virginie Trouplin;José Adélaïde;Nicola Aceto

  • Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants : An ENIGMA resource to support clinical variant classification

    Michael T. Parsons;Emma Tudini;Hongyan Li;Eric Hahnen

  • Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

    Antonis C Antoniou;Karoline B Kuchenbaecker;Penny Soucy;Jonathan Beesley

  • Comprehensive annotation of splice junctions supports pervasive alternative splicing at the BRCA1 locus: a report from the ENIGMA consortium

    Mara Colombo;Marinus J. Blok;Phillip Whiley;Phillip Whiley;Marta Santamarina

  • Genotype-phenotype correlations in hereditary familial retinoblastoma.

    Melissa Taylor;Catherine Dehainault;Laurence Desjardins;François Doz

  • Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms.

    Miguel De La Hoya;Omar Soukarieh;Irene López-Perolio;Ana Vega

Frequent Co-Authors

Amanda B. Spurdle
Amanda B. Spurdle QIMR Berghofer Medical Research Institute
François Doz
François Doz Université Paris Cité
Fergus J. Couch
Fergus J. Couch Mayo Clinic
Paolo Radice
Paolo Radice Fondazione IRCCS Istituto Nazionale dei Tumori
Barbara Wappenschmidt
Barbara Wappenschmidt University of Cologne
Thierry Frebourg
Thierry Frebourg Grenoble Alpes University
Irene L. Andrulis
Irene L. Andrulis University of Toronto
Melissa C. Southey
Melissa C. Southey Monash University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in genetics but also exploring other healthcare career avenues? There are a variety of online degree options and accelerated pathways that can help you start or advance your career quickly. For registered nurses aiming to further their education with more flexibility, choosing an rn to bsn without clinicals program can offer the chance to earn your bachelor’s degree online without the need for on-site clinical requirements.

For those seeking advanced practice roles, pursuing the fastest dnp online program or enrolling in one of the cheapest dnp programs can help you achieve a terminal nursing degree in less time or at a lower financial cost.

If you’re just starting out, a medical assistant course can be completed in as little as six weeks, providing a quick entry point into the healthcare field. Whether you’re aiming for clinical, administrative, or research-focused roles, these flexible online options make it easier to pursue a career path in science and healthcare.

Best Scientists Citing Claude Houdayer

Trending Scientists

Recently Published Articles